McGraw Hill, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on July 23, 2025, with the Initial Public Offering (IPO) closing on July 25, 2025. McGraw Hill, Inc. (Delaware) announced the pricing of its IPO, marking its transition to a publicly traded company on the New York Stock Exchange under the symbol MH.
Key Financial Metrics and Transaction Details
- Offering Price: $17.00 per share.
- Shares Offered by Company: 24,390,000 shares of Common Stock.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 3,658,500 shares from the Selling Stockholder (PE MAV Holdings, LLC).
- Underwriters: Goldman Sachs & Co. LLC and several others listed in the Underwriting Agreement.
- Financial Performance: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period.
Material Changes and Corporate Actions
- Material Definitive Agreement: Entered into an Underwriting Agreement on July 23, 2025, governing the sale of shares.
- Investor Rights: Executed an Investor Rights Agreement with the Selling Stockholder, effective July 25, 2025.
- Governance Changes: Filed a Second Amended and Restated Certificate of Incorporation and adopted Amended and Restated Bylaws, both effective July 23, 2025.
- Capital Structure: Common Stock ($0.01 par value) is now registered under Section 12(b) of the Exchange Act.
Guidance, Outlook, and Risks
The filing includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ significantly from management's current beliefs due to various risks and uncertainties. The Company assumes no obligation to update these statements except as required by law. No specific financial guidance or outlook metrics are provided in this text.
Key Facts for Investor Verification
- Verify the final closing price and trading volume on the New York Stock Exchange following the July 25, 2025, closing.
- Confirm whether the underwriters exercised the 3,658,500 share over-allotment option within the 30-day window.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for lock-up periods and indemnification terms.
- Examine the Second Amended and Restated Certificate of Incorporation (Exhibit 3.1) for specific provisions regarding director elections and shareholder rights.
- Check the Registration Statement (Form S-1, File No. 333-288373) for detailed financial statements and risk factors not included in this 8-K summary.